Core Viewpoint - Aide Technology Co., Ltd. (爱得科技) has successfully listed on the Beijing Stock Exchange, with a closing price of 21.23 yuan, reflecting a significant increase of 176.79% on its first day of trading, and a total market capitalization of 2.508 billion yuan [1]. Company Overview - Aide Technology specializes in the research, production, and sales of orthopedic medical devices, focusing on products such as spinal, trauma, and sports medicine consumables, as well as wound healing products [1]. - The company aims to become a leading provider of comprehensive orthopedic surgical solutions in China, guided by clinical needs in orthopedics [1]. Shareholding Structure - As of the signing date of the prospectus, Lu Qiang holds 34.99% and Huang Meiyu holds 38.78% of the shares directly, with an additional 5.29% controlled through a management company, totaling 79.07% of shares held or controlled by the couple, who are the controlling shareholders [1]. Financial Highlights - The company reported revenues of 285.60 million yuan in 2022, 262.11 million yuan in 2023, and projected revenues of 307.48 million yuan for 2025, indicating an expected growth of 11.87% compared to 2024 [5][7]. - Net profits for the same periods were 93.39 million yuan (2022), 63.57 million yuan (2023), and a projected 76.51 million yuan for 2025, reflecting a growth of 14.56% from 2024 [5][7]. - The company’s total assets as of June 30, 2025, were approximately 652.06 million yuan, with total equity of about 543.81 million yuan [6]. Fundraising and Investment Plans - Aide Technology issued 29,530,762 shares at a price of 7.67 yuan per share, raising a total of approximately 226.50 million yuan, with a net amount of about 196.99 million yuan after expenses [2]. - The funds will be allocated to three main projects: orthopedic consumables expansion (approximately 102.48 million yuan), research center construction (approximately 52.66 million yuan), and marketing network development (approximately 41.88 million yuan) [4].